Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 3, September

Preface

Volume:2   Issue: 3
Pp: i-i
Francis J. Castellino
DOI: 10.2174/1389450013348362
Published on: 01 March, 2012

NMDA Receptor Pharmacology: Perspectives from Molecular Biology

Volume:2   Issue: 3
Pp: 215-231
David R. Lynch and Rodney P. Guttmann
DOI: 10.2174/1389450013348434
Published on: 01 March, 2012

Subunit Characterization of NMDA Receptors

Volume:2   Issue: 3
Pp: 233-239
F. Anne Stephenson
DOI: 10.2174/1389450013348461
Published on: 01 March, 2012

Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies

Volume:2   Issue: 3
Pp: 241-271
Gene C. Palmer
DOI: 10.2174/1389450013348335
Published on: 01 March, 2012

NMDA Receptors and Learning and Memory Processes

Volume:2   Issue: 3
Pp: 273-283
C. Castellano, V. Cestari and A. Ciamei
DOI: 10.2174/1389450013348515
Published on: 01 March, 2012

Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action

Volume:2   Issue: 3
Pp: 285-298
Keith Williams
DOI: 10.2174/1389450013348489
Published on: 01 March, 2012

Convergence of PKC-Dependent Kinase Signal Cascades on NMDA Receptors

Volume:2   Issue: 3
Pp: 299-312
J. F. Macdonald, S. A. Kotecha, W. Y. Lu and M. F. Jackson
DOI: 10.2174/1389450013348452
Published on: 01 March, 2012

Structure-Function Relationships of the NMDA Receptor Antagonist Conantokin Peptides

Volume:2   Issue: 3
Pp: 313-322
Mary Prorok and Francis J. Castellino
DOI: 10.2174/1389450013348542
Published on: 01 March, 2012

Activators and Inhibitors of the Ion Channel of the NMDA Receptor

Volume:2   Issue: 3
Pp: 323-329
Rebecca C. Klein and Francis J. Castellino
DOI: 10.2174/1389450013348290
Published on: 01 March, 2012

The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors

Volume:2   Issue: 3
Pp: 331-345
Joseph R. Moskal, Hirotaka Yamamoto and Patricia A. Colley
DOI: 10.2174/1389450013348399
Published on: 01 March, 2012